Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
We have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources we...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1075 |
_version_ | 1797297850164445184 |
---|---|
author | Mohammad Nouri Sharikabad Svetlana Skurtveit Hilchen Thode Sommerschild Kristine Olsen Ingeborg Hartz Rikke Wesselhoeft Vidar Hjellvik Lars Johan Hauge Marte Handal |
author_facet | Mohammad Nouri Sharikabad Svetlana Skurtveit Hilchen Thode Sommerschild Kristine Olsen Ingeborg Hartz Rikke Wesselhoeft Vidar Hjellvik Lars Johan Hauge Marte Handal |
author_sort | Mohammad Nouri Sharikabad |
collection | DOAJ |
description | We have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources were (i) prescription data from the Norwegian Prescription Database linked to specialist health care diagnoses from the Norwegian Patient Registry and (ii) sleep disorder diagnoses from the Primary Health Care Database. Hypnotic drugs were defined as the sedative antihistamine alimemazine and the ATC group “Hypnotics and Sedatives” (N05C), excluding midazolam. In 2017, 2519 girls (16.5/1000) and 1718 boys (10.7/1000) were incident (new) users of hypnotic drugs. Most of these new users (82% of girls, 77% of boys) were referred to secondary health care, where the most frequent diagnoses were mental and behavioral disorders (51.8% of girls, 46.2% of boys), while only 3.2% received a specific sleep disorder diagnosis. The most common mental and behavioral disorders were “Neurotic stress-related disorders” among girls (27.4%) and “Behavioral and emotional disorders” among boys (23.6%). In conclusion, the trend of increasing hypnotic drug use among adolescents reflects the initiation of hypnotic drugs in a subgroup of the population with a higher disease burden, mainly due to psychiatric disorders, than the general population. |
first_indexed | 2024-03-07T22:26:23Z |
format | Article |
id | doaj.art-193a7bfe334c4b73b61f5b141702a884 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-07T22:26:23Z |
publishDate | 2024-02-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-193a7bfe334c4b73b61f5b141702a8842024-02-23T15:22:13ZengMDPI AGJournal of Clinical Medicine2077-03832024-02-01134107510.3390/jcm13041075Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based StudyMohammad Nouri Sharikabad0Svetlana Skurtveit1Hilchen Thode Sommerschild2Kristine Olsen3Ingeborg Hartz4Rikke Wesselhoeft5Vidar Hjellvik6Lars Johan Hauge7Marte Handal8Department of Drug Statistics, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayNorwegian Board of Health Supervision, 0213 Oslo, NorwayDepartment of Drug Statistics, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayChild and Adolescent Mental Health Southern Denmark, Mental Health Services in the Region of Southern Denmark, 5000 Odense C, DenmarkDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Mental Health and Suicide, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayWe have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources were (i) prescription data from the Norwegian Prescription Database linked to specialist health care diagnoses from the Norwegian Patient Registry and (ii) sleep disorder diagnoses from the Primary Health Care Database. Hypnotic drugs were defined as the sedative antihistamine alimemazine and the ATC group “Hypnotics and Sedatives” (N05C), excluding midazolam. In 2017, 2519 girls (16.5/1000) and 1718 boys (10.7/1000) were incident (new) users of hypnotic drugs. Most of these new users (82% of girls, 77% of boys) were referred to secondary health care, where the most frequent diagnoses were mental and behavioral disorders (51.8% of girls, 46.2% of boys), while only 3.2% received a specific sleep disorder diagnosis. The most common mental and behavioral disorders were “Neurotic stress-related disorders” among girls (27.4%) and “Behavioral and emotional disorders” among boys (23.6%). In conclusion, the trend of increasing hypnotic drug use among adolescents reflects the initiation of hypnotic drugs in a subgroup of the population with a higher disease burden, mainly due to psychiatric disorders, than the general population.https://www.mdpi.com/2077-0383/13/4/1075hypnotics and sedativesmelatoninadolescentsleep disorderssleep disturbancesmental disorders |
spellingShingle | Mohammad Nouri Sharikabad Svetlana Skurtveit Hilchen Thode Sommerschild Kristine Olsen Ingeborg Hartz Rikke Wesselhoeft Vidar Hjellvik Lars Johan Hauge Marte Handal Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study Journal of Clinical Medicine hypnotics and sedatives melatonin adolescent sleep disorders sleep disturbances mental disorders |
title | Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study |
title_full | Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study |
title_fullStr | Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study |
title_full_unstemmed | Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study |
title_short | Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study |
title_sort | morbidity among adolescent hypnotic drug users in norway an observational population based study |
topic | hypnotics and sedatives melatonin adolescent sleep disorders sleep disturbances mental disorders |
url | https://www.mdpi.com/2077-0383/13/4/1075 |
work_keys_str_mv | AT mohammadnourisharikabad morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT svetlanaskurtveit morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT hilchenthodesommerschild morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT kristineolsen morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT ingeborghartz morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT rikkewesselhoeft morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT vidarhjellvik morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT larsjohanhauge morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy AT martehandal morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy |